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Tuberculosis (TB) is a pulmonary infectious disease which is the main cause of increased morbidity 
and mortality worldwide. Diabetes mellitus is one of the factors that can increase the incidence of 
pulmonary tuberculosis. This study aims to determine changes in glucose levels in pulmonary TB 
patients at the beginning of being diagnosed with pulmonary TB or before receiving OAT therapy and 
after receiving OAT therapy. This study is an analytical study with a cross-sectional repeated 
measurement design, namely measuring blood glucose levels repeatedly for 2 times (the initial 
measurement of treatment before receiving OAT therapy and measurement after receiving OAT 
therapy). The sample in this study were 107 pulmonary tuberculosis patients who were treated at the 
Public Health Center in Palembang City. The sampling technique is proportional random sampling. 
Data analysis in this study was carried out descriptively and analytically using the t-test (Wilcoxon). 
The results showed that in TB patients with normal initial glucose level status, there was a significant 
difference in glucose levels before and after receiving OAT therapy (p-value = 0.000) p <α, TB 
patients experienced binding of glucose levels after receiving OAT therapy while in TB patients with 
DM status, showed no significant difference in glucose levels before and after receiving OAT therapy 
(p-value = 0.135) p> α. 
 




 Pulmonary tuberculosis is a 
contagious disease caused by 
Mycobacterium tuberculosis. 
Mycobacterium tuberculosis is an aerobic 
germ that can live mainly in the lungs or 
other parts of the body that have high 
oxygen pressure. This germ is in the form 
of a slender, straight or slightly bent stem 
with rounded ends, and has a high-fat 
content in the cell membrane, thus causing 
acid resistance and slow growth.1 TB 
disease is a worldwide health problem 
because one-third of the world's population 
is currently infected with tuberculosis. 
Data from the 2016 Annual Tuberculosis 
Report, patients with pulmonary 
tuberculosis in 2014 worldwide were 9.6 
million, new cases of pulmonary 
tuberculosis in 2009 occurred in the Asia 
region by 50%, where Indonesia ranks fifth 
after India, China, South Africa, and 
Nigeria. Indonesia is also the second-
largest contributor to pulmonary 
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 The high number of pulmonary 
tuberculosis cases is influenced by the 
body's immune system, and several cases 
such as HIV, malnutrition, poverty, and 
population density. Apart from these 
factors, several studies have shown that 
diabetes mellitus can also increase the risk 
of pulmonary tuberculosis. Diabetes 
mellitus is a condition characterized by 
increased blood sugar levels and has long-
term complications involving blood 
vessels, eyes, and kidneys. This disease 
affects many people who have an 
unhealthy lifestyle, namely high 
nutritional intake but low physical activity. 
 Similar to the prevalence of 
pulmonary tuberculosis, the annual 
prevalence of diabetes mellitus is also 
high. Based on data from the World Health 
Organization (WHO), Indonesia now 
ranks 4th in the number of people with 
diabetes mellitus in the world. In theory, 
diabetes mellitus affects the body's 
immune system, so that sufferers are more 
prone to contracting infections including 
Mycobacterium Tuberculosis infection. 
Patients with diabetes mellitus, including 
tuberculosis, were more common in the 
low-moderate socio-economic group. 
Several studies have shown that 
diabetes mellitus can cause differences in 
clinical manifestations and responses to 
pulmonary tuberculosis treatment, 
especially when the blood sugar levels in 
the patient are high.4 The condition of 
hyperglycemia is a marker of disease 
severity and a good predictor in conditions 
of infection, sepsis, and critical illness.4 In 
a case study- Incontrast to other studies 
that stated that the presence of 
hyperglycemia in TB patients did not 
affect treatment outcomes.6 In a study 
conducted by José Moreira, et al, it was 
found that TB patients with HIV 
coinfection had recently started treatment 
with hyperglycemic TB. , has a worse TB 
treatment result than euglycemia. 7 
 Based on the background 
description above, as a basis, the 
researcher wanted to know the changes in 
blood glucose levels in pulmonary TB 
patients as an effort to increase the success 
of pulmonary tuberculosis treatment. 
 The formulation of the problem in 
this monograph is whether there is a 
change in blood glucose levels in 
pulmonary TB patients before and after 
OAT therapy as an effort to increase the 
success of pulmonary tuberculosis 
treatment. 
 The research objectives of early 
detection of changes in blood glucose 
levels as an effort to increase the success 
of pulmonary tuberculosis treatment in this 
monograph were to determine the blood 
glucose levels in the early phase of 
treatment before receiving OAT therapy in 
pulmonary TB patients, to determine the 
blood glucose levels of pulmonary TB 
patients after receiving OAT therapy and 
to find out changes blood glucose levels of 
pulmonary TB patients before and after 




The research design used a cross-
sectional repeated measurement design, 
namely measuring blood glucose levels 
repeatedly for two measurements. In this 
study, the initial measurements were 
carried out in pulmonary TB patients 
before receiving OAT therapy and three 
months after receiving OAT therapy. The 
study was conducted in the Palembang 
City Health Center Work Area in 2019. 
The study population was all pulmonary 
tuberculosis patients in Palembang City. 
The sample in this study were some 
pulmonary tuberculosis patients who were 
treated at the Public Health Center in 
Palembang City. There were as many as 
107 samples. Descriptive analysis in this 
study is presented in the form of numbers 
and percentages. Meanwhile, the 
inferential analysis used Wilcoxon 
statistical test to determine differences in 
blood glucose levels before and after 
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receiving OAT therapy in pulmonary TB 
patients. 
 
3. RESULTS  
 
The results of the study were 
collected as many as 107 pulmonary TB 
patients with pulmonary TB patient age, 
namely 45 years with a minimum age of 
10 years and a maximum age of 85 years. 
The most age found in this study occurred 
at the age of 20-59 years, as many as 78 
people (72.9%), while those aged> 60 
years were 21 people (19.6%) and at least 
at the age <20 years 8 people (7.5%). 
Based on gender, pulmonary TB patients 
in this study were mostly found to be 
male, as many as 65 people (60.7%) 
compared to 42 people (39.3%) (Table 1).
Table 1. Frequency Distribution Based on Age and Gender 
Characteristics Total (n) Percent (%) 
Age   
- < 20 year 8 7,5 
- 20 – 59 year 78 72,9 
- > 60 year 21 19,6 
Gender   
- Male  65 60,7 
- Female  42 39,3 
 
Results of Measurement of Glucose Levels in Pulmonary TB Patients 
Distribution based on blood glucose levels 
in patients with pulmonary tuberculosis. 
The results of measuring the initial glucose 
level of TB patients or before receiving 
OAT therapy were divided into two 
categories, namely normal and diagnosed 
diabetes mellitus. The measurement results 
of pulmonary TB patients who had normal 
glucose levels were 86 patients (80.4%) 
while those diagnosed with diabetes 
mellitus (blood sugar levels> 200mg / dL) 
were 21 patients (19.6%). Whereas in the 
last measurement in pulmonary TB 
patients with normal initial blood sugar 
levels and becoming uncontrolled, it 
increased by 23 people (21.5%) (Table 2). 
 
Table 2. Frequency Distribution Based on the Results of Measurement of Glucose 
Levels in Pulmonary TB Patients 
Measurement Results Total (n) Percent (%) 
Initial Measurement 
- Normal 
Mean±SD =110±33,17, min=36, max=198 
86 80,4 
- DM 
Mean±SD = 296±75,43, min=209, max=449 
21 19,6 
Final Measurement   
- Controlled 
      Mean±SD = 121,75±27,64, min = 61, max =200 
84 78,5 
- Non-Controlled 
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Differences in glucose levels before drug 
therapy and after receiving drug 
therapy in TB patients 
 The results of glucose research 
before and after receiving anti-tuberculosis 
drug therapy (OAT) were analyzed using 
the Wilcoxon test. Pulmonary TB patients 
with initial glucose level status in the 
normal category were 86 patients and 21 
TB patients were diagnosed with DM. The 
results of the analysis of glucose levels 
before and after receiving OAT therapy in 
the group of TB patients who had initial 
glucose levels showed that there were 
differences in glucose levels before and 
after receiving OAT therapy (p value = 
0.000) p <α. Pulmonary TB patients who 
were diagnosed with TB at the start of 
normal glucose level measurements after 3 
months of receiving OAT therapy 
experienced an increase in glucose levels. 
Whereas in pulmonary TB patients who 
had initial glucose levels in the DM 
category as many as 21 patients, the results 
of the analysis were no differences in 
sugar levels before and after receiving 
OAT therapy (p value = 0.135)p> α. 
 
Table 3. Differences in glucose levels before and after receiving OAT therapy  
based on glucose status 
Normal 
Glucose Status 
Therapy n Mean ±SD 
(Min-Max)  
p value 





 After OAT therapy 86 124,95±37,14 
(61-329) 
DM Before OAT therapy 21 296,19±75,43 
(209-449) 
0,135 





 Characteristics of pulmonary TB 
patients mostly occurred in men (60.7%) 
than women (39.3%). This is consistent 
with several studies which state that men 
are indeed more susceptible to infection 
with M. tuberculosis. This can be related 
to a greater smoking habit in men, which 
causes disorders of the immune system of 
the respiratory tract, making them more 
susceptible to infection.16 Disorders of the 





be in the form of damage to mucociliary 
clearance due to toxins in inhaled cigarette  
smoke. Cigarette smoke can also damage 
phagocyte cells in the respiratory tract and 
decrease the response to antigens, thereby 
increasing the susceptibility of pulmonary 
tuberculosis.17 WHO (2012) also states 
that according to several studies, the 
incidence of pulmonary TB in women is 
lower than in men because less than 
women with pulmonary TB go to health 
care facilities. This happens because 
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women tend to find it more difficult to 
access health service facilities. The 
community's negative stigma about 
pulmonary TB affects the psychosocial 
aspects of women more than men so that 
women tend to choose not to go to health 
service facilities.16 The increasing age 
factor also affects the incidence of TB. In 
this study, it was found that almost all TB 
patients were in the age range of 20-59 
years (72.9%). This is also in accordance 
with several other studies. According to 
Tabrani (2010), patients over 40 years of 
age are more susceptible to infection with 
M. tuberculosis. This is due to the 
biological changes that occur in the 
patient's body, especially in lung tissue, 
associated with aging. These changes can 
damage the barrier system and the 
microbial clearance mechanism of the 
respiratory system.18 The study, which was 
conducted in Semarang, showed that the 
results of patients with TB-DM were more 
common in patients aged 16-50 years, 
married, middle income. This vast age 
range suggests that pulmonary TB patients 
can occur at any age. This is because TB 
infection is also influenced by the 
environment and low immunity status. 
Women of reproductive age are more 
prone to developing TB than men in the 
same age range.25 
 The results of the study on 
differences in blood glucose levels before 
and after receiving OAT therapy found 
that pulmonary TB patients with initial 
glucose level status in the normal category 
were 86 patients, the analysis showed that 
there was a significant difference in 
glucose levels before and after receiving 
OAT therapy (p value = 0,000). <α, 
glucose levels in TB patients have 
increased after receiving OAT therapy. 
 This research is in line with the 
results of the Gopathi kk study in 2015 
which stated that there was an effect of 
OAT and tuberculosis on increasing blood 
sugar levels.23 TB patients are at risk of 
experiencing DM, one of which is due to 
the impact of TB drugs in the pancreas 
which causes a decrease in insulin levels, 
which can increase blood sugar. Anti-
tuberculosis drugs commonly used are 
bactericides such as rifampin, isoniazid, 
pyrazinamide, streptomycin, and 
bacteriostatic such as ethambutol.24 
Isoniazid and rifampin have a 
hyperglycemic effect. Pyrazinamide can 
cause difficult DM control. Rifampin 
induces metabolism and lowers blood 
sulfonylurea levels.12 This drug can induce 
hyperglycemia in the early phase 
associated with increased absorption in the 
intestine, but there have been no apparent 
cases of diabetes.23 Apart from the anti-
tuberculosis drugs themselves, TB disease 
can make TB patients susceptible to DM 
because the inflammation caused by 
cytokines such as IL6 and TNFα in 
response to TB infection can lead to 
increased insulin resistance and decreased 
insulin production, leading to 
hyperglycemia.12 The mechanism of 
damage to the pancreas due to tuberculosis 
is probably caused by a mycobacterial 
attack directly to the pancreas through the 
spread of bacterial tubercles in the blood 
or through the penetration of the tissue of 
the abdominal lymph nodes around the 
pancreas. It was reported that when the 
pancreas is calcified there is a 23-50% 
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 Based on the results of research on 
early detection of changes in blood 
glucose levels as an effort to increase the 
success of pulmonary tuberculosis 
treatment, it can be concluded that in 
patients with normal blood sugar status 
before OAT therapy there was a 
statistically significant difference (p value 
= 0.000) p <α, the patient's glucose level. 
TB has increased after receiving OAT 
therapy, while TB patients with DM status 
showed no significant difference in 
glucose levels before and after receiving 
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